Maciej Banach: Navigating Therapeutic Complexity in Cardiometabolic Disease Prevention
Maciej Banach, Chief Medical Officer at Graylight Imaging, Visiting Senior Research Fellow at Liverpool Centre for Cardiovascular Science, Adjunct Professor at The Johns Hopkins University School of Medicine, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Progress in Cardiovascular Diseases, adding:
“See our recent paper on a critically important topic: how to deliver effective CVD prevention for patients with multimorbidity and multiple concurrent risk factors, each often requiring several interventions or medications (oral, subcutaneous) with different dosing schedules.
In other words: how can we achieve effective, patient-centered CVD prevention overall after successfully managing individual risk factors?
‘The goal of modern cardiometabolic medicine should be maximal clinical benefit through minimal therapeutic friction (complex regimens, side-effects, monitoring requirements, adherence, high costs, limited access, etc.).
Only by aligning our rapid pace of innovation with the pragmatic constraints of real world care can we ensure that the ‘era of polypharmacy’ leads to better outcomes rather than just more prescriptions.'”
Title: Beyond therapeutic maximalism: Prioritization and personalization in preventive therapies
Authors: Yashendra Sethi, Kunal Mahajan, Michael D. Shapiro, Maciej Banach
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 7, 2026, 16:21Hannah Omunakwe: When Blood Becomes the Limiting Treatment in Sickle Cell Disease
-
Jul 7, 2026, 15:54Barbara Lovrencic: Giving the ITP Patient Voice a Stronger Evidence Base
-
Jul 7, 2026, 15:45Maria Cherska: Can Cardiovascular Prevention Become Truly Personalized If We Ignore Ethnicity?
-
Jul 7, 2026, 15:42Julie Makani: The London Patient – A Milestone in HIV Cure
-
Jul 7, 2026, 15:39July Issue is Now Live – The Lancet Haematology
-
Jul 7, 2026, 15:33Flora Peyvandi: Immune-Mediated Hepatitis After Gene Therapy
-
Jul 7, 2026, 15:31Edward Lee Carter: Understanding Ketorolac Dosing When More Is Not Always Better
-
Jul 7, 2026, 15:18Vicky Probert: A Lifelong Commitment to Saving Lives Through Blood Donation
-
Jul 7, 2026, 15:00Eliot Vichinsky Honoured with ASH Lifetime Achievement Award in Hematology – TIF